BOSTON — The Massachusetts legislature took up a highly debated public health proposal today, as lawmakers on Beacon Hill held a hybrid public hearing on whether to allow supervised drug consumption sites — state-regulated centers where people could use illegal substances under medical supervision — as part of a broader harm reduction strategy to combat the opioid crisis.
The Joint Committee on Mental Health, Substance Use and Recovery held the hybrid public hearing at 11 a.m. in the Gardner Auditorium at the State House. The hearing, titled “Harm Reduction,” focused on bills, such as Bill S.1242, An act relative to preventing overdose deaths and increasing access to treatment, which aim to establish a legal framework for cities and towns to authorize supervised consumption sites and expand access to treatment and harm reduction services.
Overdose prevention centers — also known as supervised consumption sites — are facilities where individuals can use pre-obtained drugs under medical supervision. Piloted in New York City and internationally, these centers are designed to reduce fatal overdoses, prevent the spread of infectious diseases, and connect people to treatment and recovery services.
According to the Massachusetts Department of Public Health, the state reported 2,323 confirmed and estimated opioid-related overdose deaths in 2023 — a near-record level. In 2022, the state released a feasibility report concluding that overdose prevention centers would be effective and could operate legally under Massachusetts law if cities or towns choose to adopt them locally.
Supporters of the legislation, which include Governor Maura Healey, argue that such facilities would help Massachusetts avoid preventable deaths and connect users with recovery resources.
Opponents, such as U.S. Attorney for Massachusetts Leah Foley, argue that supervised injection sites are “categorically illegal” under federal law and enable destructive behavior rather than helping people overcome addiction.
